Photo from wikipedia
Purpose Enteral feeding intolerance (EFI) is a frequent problem in the intensive care unit (ICU), but current prokinetic agents have uncertain efficacy and safety profiles. The current study compared the… Click to show full abstract
Purpose Enteral feeding intolerance (EFI) is a frequent problem in the intensive care unit (ICU), but current prokinetic agents have uncertain efficacy and safety profiles. The current study compared the efficacy and safety of ulimorelin, a ghrelin agonist, with metoclopramide in the treatment of EFI.
Keywords:
metoclopramide treatment;
feeding intolerance;
enteral feeding;
study
Journal Title: Gastroenterology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Gastroenterology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!